Astrana Health, Inc. (ASTH) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.06%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.06% | Share-based compensation / revenue. Period ending 2026-06-30. $40.76M ÷ $3.84B × 100 ≈ 1.06% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 3.84B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 40.76M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 100.45M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.84B | $40.76M | $100.45M | (m) | (m) | 1.06% | (m) | (m) |
| 2026-03-31 | (m) | $3.53B | $40.69M | $86.47M | (m) | (m) | 1.15% | (m) | (m) |
| 2025-12-31 | (m) | $3.18B | $38.60M | $78.53M | (m) | (m) | 1.21% | (m) | (m) |
| 2025-09-30 | (m) | $2.90B | $42.45M | $60.85M | (m) | (m) | 1.47% | (m) | (m) |
| 2025-06-30 | (m) | $2.42B | $40.92M | $70.07M | (m) | (m) | 1.69% | (m) | (m) |
| 2025-03-31 | (m) | $2.25B | $36.60M | $79.79M | (m) | (m) | 1.63% | (m) | (m) |
| 2024-12-31 | (m) | $2.03B | $34.54M | $89.35M | (m) | (m) | 1.70% | (m) | (m) |
| 2024-09-30 | (m) | $1.72B | $27.98M | $84.76M | (m) | (m) | 1.62% | (m) | (m) |
| 2024-06-30 | (m) | $1.59B | $27.52M | $95.42M | $25.37M | (m) | 1.73% | 3.76× | Reported |
| 2024-03-31 | (m) | $1.45B | $24.34M | $92.38M | $20.42M | (m) | 1.67% | 4.52× | Reported |
| 2023-12-31 | (m) | $1.39B | $22.04M | $84.61M | $16.10M | (m) | 1.59% | 5.25× | Reported |
| 2023-09-30 | (m) | $1.33B | $18.99M | $101.06M | $13.25M | (m) | 1.43% | 7.63× | Reported |
| 2023-06-30 | (m) | $1.30B | $16.78M | $112.07M | $11.89M | (m) | 1.29% | 9.42× | Reported |
| 2023-03-31 | (m) | $1.22B | $16.49M | $100.43M | $10.12M | (m) | 1.35% | 9.93× | Reported |
| 2022-12-31 | (m) | $1.14B | $16.10M | $104.27M | $7.92M | (m) | 1.41% | 13.16× | Reported |
| 2022-09-30 | (m) | $1.05B | $12.90M | $93.93M | $6.40M | (m) | 1.23% | 14.68× | Reported |
| 2022-06-30 | (m) | $955.17M | $10.82M | $97.00M | $4.95M | (m) | 1.13% | 19.62× | Reported |
| 2022-03-31 | (m) | $861.12M | $8.45M | $102.61M | $4.94M | (m) | 0.98% | 20.75× | Reported |
| 2021-12-31 | (m) | $773.91M | $6.75M | $98.18M | $5.39M | (m) | 0.87% | 18.20× | Reported |
| 2021-09-30 | (m) | $755.60M | $5.15M | $121.81M | $5.83M | (m) | 0.68% | 20.88× | Reported |
| 2021-06-30 | (m) | $708.60M | $4.38M | $106.00M | $7.33M | (m) | 0.62% | 14.45× | Reported |
| 2021-03-31 | (m) | $698.13M | $3.67M | $97.92M | $8.15M | (m) | 0.53% | 12.01× | Reported |
| 2020-12-31 | (m) | $687.18M | $3.38M | $80.50M | $9.50M | (m) | 0.49% | 8.47× | Reported |
| 2020-09-30 | (m) | $689.15M | $3.10M | $65.56M | $11.39M | (m) | 0.45% | 5.76× | Reported |
| 2020-06-30 | (m) | $665.09M | $2.78M | $38.27M | $9.75M | (m) | 0.42% | 3.92× | Reported |
| 2020-03-31 | (m) | $629.97M | $2.26M | $40.09M | $7.39M | (m) | 0.36% | 5.42× | Reported |
| 2019-12-31 | (m) | $560.62M | $1.55M | $32.42M | $4.73M | (m) | 0.28% | 6.85× | Reported |
| 2019-09-30 | (m) | $488.46M | (m) | $23.49M | $1.54M | (m) | (m) | 15.29× | Reported |
| 2019-06-30 | (m) | $499.12M | (m) | $70.00M | $886.86K | (m) | (m) | 78.93× | Reported |
| 2019-03-31 | (m) | (m) | (m) | $62.42M | $686.49K | (m) | (m) | 90.93× | Reported |
| 2018-12-31 | (m) | $519.91M | (m) | $88.43M | $560.51K | (m) | (m) | 157.77× | Reported |
| 2018-09-30 | (m) | $508.42M | (m) | $80.59M | $437.32K | (m) | (m) | 184.27× | Reported |
| 2018-06-30 | (m) | $438.27M | (m) | $45.26M | $273.99K | (m) | (m) | 165.19× | Reported |
| 2018-03-31 | (m) | $396.58M | (m) | $42.17M | $163.88K | (m) | (m) | 257.31× | Reported |
| 2017-12-31 | (m) | $357.75M | (m) | $35.15M | $79.69K | (m) | (m) | 441.04× | Reported |
| 2017-12-07 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $112.49M | (m) | $-14.42M | $469.84K | (m) | (m) | -30.70× | Reported |
| 2017-06-30 | (m) | $86.63M | (m) | $-12.48M | $273.24K | (m) | (m) | -45.69× | Reported |
| 2017-03-31 | (m) | $57.43M | (m) | $-10.54M | $82.91K | (m) | (m) | -127.10× | Reported |
| 2016-12-31 | (m) | $54.48M | (m) | $-9.34M | $27.80K | (m) | (m) | -336.05× | Reported |
| 2016-09-30 | (m) | $49.47M | (m) | $-9.13M | $118.79K | (m) | (m) | -76.82× | Reported |
| 2016-06-30 | (m) | $46.22M | (m) | $-7.36M | $184.55K | (m) | (m) | -39.90× | Reported |
| 2016-03-31 | (m) | $44.05M | (m) | $-7.27M | $542.30K | (m) | (m) | -13.40× | Reported |
| 2015-12-31 | (m) | $41.82M | (m) | $-3.37M | $887.55K | (m) | (m) | -3.80× | Reported |
| 2015-09-30 | (m) | $38.80M | (m) | $-3.44M | $1.15M | (m) | (m) | -3.00× | Reported |
| 2015-06-30 | (m) | $39.10M | (m) | $-1.17M | $1.41M | (m) | (m) | -0.83× | Reported |
| 2015-03-31 | (m) | $32.99M | (m) | $-694.33K | $1.33M | (m) | (m) | -0.52× | Reported |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-01-31 | (m) | $10.48M | $12.60K | $-3.91M | $679.18K | (m) | 0.12% | -5.76× | Reported |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-10-31 | (m) | $10.17M | (m) | $-3.41M | $736.97K | (m) | (m) | -4.63× | Reported |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-07-31 | (m) | $9.53M | (m) | $-4.03M | $779.53K | (m) | (m) | -5.18× | Reported |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-04-30 | (m) | $8.59M | (m) | $-2.74M | $833.63K | (m) | (m) | -3.28× | Reported |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-01-31 | (m) | $7.78M | (m) | $-2.08M | $930.18K | (m) | (m) | -2.23× | Reported |
| 2012-10-31 | (m) | $6.79M | (m) | $-1.82M | $643.20K | (m) | (m) | -2.83× | Reported |
| 2012-07-31 | (m) | $6.26M | (m) | $-258.73K | $476.40K | (m) | (m) | -0.54× | Reported |
| 2012-04-30 | (m) | $5.70M | (m) | $-279.04K | $302.79K | (m) | (m) | -0.92× | Reported |
| 2012-01-31 | (m) | $5.11M | (m) | $-413.33K | $131.53K | (m) | (m) | -3.14× | Reported |
| 2011-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-01-31 | (m) | $3.90M | (m) | $4.01K | $126.43K | (m) | (m) | 0.03× | Reported |
| 2010-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |
| TSS, Inc. (TSSI) | United States | $0.288B | 24.06 |
| Information Services Group Inc. (III) | United States | $0.256B | 16.97 |
| HACKETT GROUP, INC. (HCKT) | United States | $0.254B |